Tetra Tech Inc
TTEK
32.72
-0.66
-1.98%
Tetra Tech Inc
US · TTEK
#1619 by market cap
Listed 1970
32.72
-0.66
-1.98%
Live - 5344 symbols - heartbeat 450s ago
· 2026-10-08 07:40
Pre-market
32.72
0.00%
After-hours
32.72
0.00%
Overnight
32.72
0.00%
- Market cap
- 8.38B
- P/E (TTM)i
- 19.71
- P/Bi
- 4.52
- EPSi
- 0.93
- Div yieldi
- 0.82%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on TTEK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.43, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.69% YoY
Margins
- Gross margin
- 17.66%
- Operating margin
- 11.09%
- Net margin
- 4.55%
Key ratios & quality
- Enterprise valuei
- 9.04B
- Altman Z-Scorei
- 4.43
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.96B | 3.11B | 2.99B | 3.21B | 3.50B | 4.52B | 5.20B | 5.44B |
| Gross profit | 384.46M | 408.18M | 446.54M | 498.40M | 575.56M | 725.03M | 866.44M | 961.34M |
| Selling & admin expenses | 190.12M | 200.23M | 204.62M | 222.97M | 234.78M | 305.11M | 356.02M | 357.74M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 194.34M | 207.95M | 241.92M | 275.43M | 340.78M | 419.92M | 510.42M | 603.61M |
| Pretax profit | 174.56M | 175.14M | 227.99M | 266.87M | 348.77M | 400.98M | 463.47M | 377.62M |
| Tax | 37.61M | 16.38M | 54.10M | 34.04M | 85.60M | 127.53M | 130.02M | 129.67M |
| Net profit | 136.96M | 158.76M | 173.89M | 232.83M | 263.16M | 273.45M | 333.44M | 247.95M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.48 | 0.57 | 0.63 | 0.85 | 0.97 | 1.02 | 1.23 | 0.93 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.32B | 1.37B | 1.33B | 1.21B | 1.22B | 1.31B |
| Gross profit | 214.18M | 251.54M | 274.15M | 220.37M | 214.09M | 243.21M |
| Selling & admin expenses | 84.09M | 86.61M | 102.72M | 86.82M | 82.63M | 85.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 130.09M | 164.93M | 171.43M | 133.55M | 131.47M | 158.00M |
| Pretax profit | 31.11M | 156.70M | 174.50M | 141.58M | 127.34M | 150.77M |
| Tax | 25.70M | 42.82M | 46.62M | 36.35M | 33.54M | 40.97M |
| Net profit | 5.41M | 113.88M | 127.88M | 105.22M | 93.80M | 109.80M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.02 | 0.43 | 0.48 | 0.40 | 0.36 | 0.42 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.05B | 1.08B | 999.79M | 1.07B | 1.16B | 1.36B | 1.53B | 1.62B |
| Cash & ST investments | 146.19M | 120.73M | 157.52M | 166.57M | 185.09M | 168.83M | 232.69M | 167.46M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.96B | 2.15B | 2.38B | 2.58B | 2.62B | 3.82B | 4.19B | 4.28B |
| Total current liabilities | 618.09M | 769.95M | 793.46M | 848.48M | 916.02M | 1.21B | 1.22B | 1.38B |
| Short-term debt | 12.60M | 12.50M | 118.91M | 79.96M | 70.37M | 65.01M | 63.42M | 69.10M |
| Long-term debt | 264.71M | 263.93M | 242.40M | 200.00M | 246.25M | 879.53M | 812.63M | 763.36M |
| Total liabilities | 992,321,000.00 | 1,157,944,000.00 | 1,341,185,000.00 | 1,342,271,000.00 | 1,439,639,000.00 | 2,416,971,000.00 | 2,362,263,000.00 | 2,502,010,000.00 |
| Total equity | 967.10M | 989.46M | 1.04B | 1.23B | 1.18B | 1.40B | 1.83B | 1.78B |
| Retained earnings | 944.97M | 1.07B | 1.20B | 1.36B | 1.39B | 1.60B | 1.87B | 1.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.67B | 1.62B | 1.62B | 1.60B | 1.54B | 1.58B |
| Cash & ST investments | 179.43M | 242.83M | 167.46M | 269.45M | 223.61M | 230.84M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.18B | 4.35B | 4.28B | 4.26B | 4.36B | 4.39B |
| Total current liabilities | 1.52B | 1.38B | 1.38B | 1.22B | 1.23B | 1.33B |
| Short-term debt | 315.87M | 64.11M | 69.10M | 69.68M | 73.74M | 74.68M |
| Long-term debt | 764.19M | 862.48M | 763.36M | 834.26M | 880.16M | 801.06M |
| Total liabilities | 2,610,523,000.00 | 2,611,351,000.00 | 2,502,010,000.00 | 2,418,089,000.00 | 2,498,482,000.00 | 2,535,722,000.00 |
| Total equity | 1.57B | 1.74B | 1.78B | 1.85B | 1.86B | 1.85B |
| Retained earnings | 1.72B | 1.80B | 1.87B | 1.92B | 1.96B | 1.96B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 185.73M | 208.51M | 262.48M | 304.37M | 336.19M | 368.46M | 358.71M | 457.69M |
| Depreciation & amortization | 38.64M | 28.84M | 24.61M | 23.81M | 27.03M | 61.21M | 73.68M | 58.28M |
| Free cash flow | 176.01M | 192.32M | 250.23M | 295.80M | 325.61M | 341.56M | 340.57M | 439.05M |
| Dividends paid | -24.48M | -29.67M | -34.74M | -40.04M | -46.10M | -52.11M | -58.83M | -65.04M |
| Stock buybacks / issuance | -75.00M | -100.00M | -117.19M | -60.00M | -200.00M | 0 | 0 | -249.98M |
| Ending cash balance | 148.88M | 120.90M | 157.52M | 166.57M | 185.09M | 168.83M | 232.69M | 168.37M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -5.82M | 349.60M | 100.85M | 72.27M | 165.34M | 228.94M |
| Depreciation & amortization | 13.88M | 13.70M | 14.64M | 14.00M | 14.34M | 14.77M |
| Free cash flow | -11.41M | 346.11M | 94.73M | 68.12M | 159.35M | 225.13M |
| Dividends paid | -15.35M | -17.09M | -17.05M | -16.94M | -16.92M | -18.62M |
| Stock buybacks / issuance | -149.98M | -25.00M | -50.00M | -50.00M | -52.01M | -100.00M |
| Ending cash balance | 179.43M | 242.83M | 168.37M | 269.45M | 223.61M | 230.84M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.44 | 16.22 | 17.16 | 20.50 | 21.77 | 21.14 | 20.62 | 13.72 |
| ROA %i | 7.09 | 7.73 | 7.68 | 9.40 | 10.12 | 8.49 | 8.32 | 5.85 |
| ROIC %i | 11.79 | 13.63 | 12.87 | 14.83 | 16.31 | 15.36 | 13.49 | 9.55 |
| 5-year avg ROE %i | 10.44 | 11.53 | 14.13 | 16.29 | 18.02 | 19.36 | 20.24 | 19.55 |
| EBIT margin %i | 6.47 | 6.13 | 8.10 | 8.70 | 10.33 | 10.03 | 9.77 | 7.68 |
| FCF / sales %i | 5.64 | 6.19 | 8.36 | 9.20 | 9.29 | 7.55 | 6.55 | 8.07 |
| Current ratioi | 1.70 | 1.40 | 1.26 | 1.26 | 1.26 | 1.12 | 1.25 | 1.18 |
| Quick ratioi | 1.61 | 1.32 | 1.16 | 1.12 | 1.14 | 1.05 | 1.18 | 1.07 |
| Debt / assetsi | 14.15 | 12.87 | 23.26 | 17.63 | 17.65 | 28.51 | 24.24 | 23.05 |
| LT debt / equityi | 27.38 | 26.68 | 41.87 | 30.33 | 33.18 | 72.98 | 52.05 | 51.58 |
| Interest coveragei | 11.06 | 12.40 | 16.75 | 21.93 | 27.10 | 8.65 | 11.40 | 10.29 |
| Revenue CAGR (3Y) %i | 8.83 | 6.35 | 2.84 | 2.73 | 4.09 | 14.73 | 17.39 | 15.81 |
| Net income CAGR (3Y) %i | 51.88 | 23.72 | 13.83 | 19.37 | 18.37 | 16.29 | 12.71 | -1.99 |
| FCF CAGR (3Y) %i | 8.30 | 13.92 | 23.84 | 18.89 | 19.19 | 10.93 | 4.81 | 10.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.91 | 12.68 | 13.72 | 19.90 | 25.62 | 24.26 |
| ROA %i | 4.56 | 5.12 | 5.85 | 8.34 | 10.30 | 9.97 |
| ROIC %i | 7.71 | 8.71 | 9.55 | 13.39 | 16.30 | 16.35 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.25 | 6.88 | 7.68 | 10.40 | 12.49 | 12.51 |
| FCF / sales %i | 4.28 | 8.06 | 8.07 | 9.51 | 13.03 | 10.80 |
| Current ratioi | 1.10 | 1.18 | 1.18 | 1.31 | 1.25 | 1.18 |
| Quick ratioi | 1.01 | 1.10 | 1.07 | 1.22 | 1.15 | 1.09 |
| Debt / assetsi | 29.24 | 24.62 | 23.05 | 24.82 | 25.44 | 23.32 |
| LT debt / equityi | 57.66 | 57.84 | 51.58 | 53.56 | 55.60 | 51.23 |
| Interest coveragei | 8.37 | 9.64 | 10.29 | 13.43 | 15.67 | 15.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial/International Group (CIG) is the largest reported line at 55.65% of revenue, across 3 reported segments.
- Government Services Group (GSG) follows at 45.73%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial/International Group (CIG)55.65%
Government Services Group (GSG)45.73%
Quote time 2026-10-08 07:40:45 · For reference only, not investment advice and not tailored to your situation.